A shadow market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with numerous of participants share comparison photos, administration instructions and claims of rapid UK delivery. Vendors market the substance there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Experts Express Worries
However, physicians and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in users administering substances of uncertain source.
Several professionals said the popularity for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.
Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking fines, legal action or imprisonment.
Platform Response and Content Removal
According to TikTok, the platform has taken down violative content and prohibited associated hashtags and query recommendations. The company said it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.
Digital Trading Operations
Investigations also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, positive testimonials and detailed guides for preparing or injecting at residence.
Within minutes of joining one community, a seller posted WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.
Product Information and Pricing
Within these communities, posts show dark colored parcels with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When asked how long a injector should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service said it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering substances they cannot confirm. Even if the science behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may subject users to possibly significant health risks”.
